Search

Kordower, JH, TB Freeman, EY Chen, EJ Mufson, PR Sanberg, RA Hauser, B Snow, and CW Olanow. 1998. “Fetal Nigral Grafts Survive and Mediate Clinical Benefit in a Patient With Parkinson’s Disease. Movement Disorders 1998;13:383-393.”. Movement Disorders.

Sethi, KD, CF O’Brien, JP Hammerstad, CH Adler, TL Davis, RL Taylor, J Sanchez-Ramos, JM Bertoni, and RA Hauser. 1998. “Ropinirole for the Treatment of Early Parkinson’s Disease: A 12-Month Experience. Arch Neurol 1998;55:1211-1216.”. Arch Neurol.

Weiner, WJ, SA Factor, J Jankovic, RA Hauser, JW Tetrud, CH Waters, LM Shulman, and . 2001. “The Long-Term Safety and Efficacy of Pramipexole in Advanced Parkinson’s Disease. Parkinsonism and Related Disorders 2001;7(2)115-120.”. Parkinsonism and Related Disorders.

Hauser, RA, L Zeitlin, S Fisher, and R D’Souza. 2021. “Duration of Benefit Per Dose: Carbidopa-Levodopa Immediate Release Vs. Extended Release Capsules (Rytary®). Parkinsonism Relat Disord 2021;82:133-137.”. Parkonsonism Relat Disord.

Patel, AT, MF Lew, K Dashtipour, S Isaacson, RA Hauser, W Ondo, P Maisonobe, S Wietek, B Rubin, and A Brashear. 2021. “Sustained Functional Benefits After a Single Set of Injections With AbobotulinumtoxinA Using a 2-ML Injection Volume in Adults With Cervical Dystonia: 12-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3b Study.”. ECollection.

Hauser, RA, WG Ondo, L Zhang, A Bowling, B Navia, E Pappert, and SH Isaacson. 2023. “Study Investigators. Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary? 2023 Mar 22. Doi: 10.3233/JPD-223537. 2023;13(3):403-414. PMID: 36970914”. J Parkinsons Dis.

Morinan, G, RA Hauser, A Schrag, J Tang, J O’Keeffe, and MDS-NMS Scale Development Study Group. 2022. “Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search. Parkinsons Dis. 2022 Jun 7;2022:2920255. Doi: 10.1155/2022/2920255. ECollection 2022. PMID: 35711334”. Parkinsons Dis.

Hauser, RA, I Biaggioni, LA Hewitt, and S Vernino. 2018. “Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson Disease. Mov Disord Clin Pract 2018;5:627-634.”. Mov Disord Clin Pract.

Hauser, RA, R Li, A Perez, X Ren, D Weintraub, J Elm, JL Goudreau, et al. 2017. “NINDS NET-PD Investigators. Longer Duration of MAO-B Inhibitor Exposure Is Associated With Less Clinical Decline in Parkinson’s Disease: An Analysis of NET-PD LS1. J Parkinsons Dis 2017;7:117-127.”. J Parkinsons Dis.

Tilley, BC, AG Mainous, DW Smith, MD McKee, RP Amorrortu, J Alvidrez, V Diaz, et al. 2017. “Design of a Cluster-Randomized Minority Recruitment Trial: RECRUIT. Clin Trials 2017;14:286-298.”. Clin Trials.